Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Recursion Pharmaceuticals, Inc. operates as a biotechnology firm currently in its clinical development phase.

52W Range

13thpctl

Volume

0.58×avg

Market Cap

1.75BUSD

P/E Ratio

-3.2TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Recursion Pharmaceuticals, Inc.

RXRXNASDAQ Global Select·USD·Closed

Recursion Pharmaceuticals, Inc.

RXRXNASDAQ·USD·Closed

$3.34

−2.91%

$3.34

−$0.10 (2.91%)

52W Range

13thpctl

Volume

0.58×avg

Mkt Cap

1.75BUSD

P/E

-3.2TTM

Div Yield

–ann

RXRX: Recursion Pharmaceuticals, Inc. Stock Analysis | finqOS